|Articles|March 1, 2000

Creating an Optimal Strategy for Managing Hypertension
Volume 6
Issue 4 Suppl

Clinical Overview of Antihypertensive Classes - Clinically Relevant Differences: Myths or Facts?

Author(s)Alan H. Gradman, MD

Download PDF: Clinical Overview of Antihypertensive Classes - Clinically Relevant Differences: Myths or Facts?

Articles in this issue

over 26 years ago

Article

Participating Faculty

over 26 years ago

Article

Introduction

over 26 years ago

Article

The Impact of the New HEDIS Guidelines: Practical Considerations

over 26 years ago

Article

Critical Overview of Antihypertensive Therapies: What is Preventing Us from Getting There?

over 26 years ago

Article

Impact and Risks of Untreated Hypertension on Managed Care

over 26 years ago

Article

Closing Remarks

over 26 years ago

Article

CE Quiz

over 26 years ago

Article

Selected Abstracts

over 26 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Clinical Overview of Antihypertensive Classes - Clinically Relevant Differences: Myths or Facts?

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor